Development and evaluation of cocrystals of Efavirenz
Project 433
Problem to be solved
-
Drug with low bioavailability oral
Proposed innovation
-
New crystal structure of efavirenz with application possibility for adult and pediatric formulations with increased bioavailability and lower dosage
Differential
-
• Greater dissolution and bioavailability due to the change of the crystalline form of the drug already in use.
• Employed in formulations for adult patients and in specific formulations for pediatric treatment. Employed in formulations for adult patients and in specific formulations for pediatric treatment.
Stage of development
-
Laboratory prototype
What we want
-
Transference of technology
Coordinator
-
Helvécio Vinícius Antunes Rocha / Farmanguinhos
Contact
- Gestec/VPPIS – phone: 21 3882 9099/ 3882 9120 or portfolio@fiocruz.br